Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

In Pakistan, Vaccinating Children Has Become a Deadly Battle

February 18, 2015 8:38 am | by Rebecca Santana, Associated Press | News | Comments

While vaccine distrust has sparked debates amid a measles outbreak in the United States, Pakistan is in a deadly battle to wipe out polio. Read more...                  


Link Between Genetic Switch, Autoimmune Diseases

February 17, 2015 12:53 pm | by NIH | News | Comments

Investigators with the National Institutes of Health have discovered the genomic switches of a blood cell key to regulating the human immune system. The findings, published in Nature, open the door to new research and development in drugs and personalized medicine to help those with autoimmune disorders such as inflammatory bowel disease or rheumatoid arthritis. Read more...


Ovarian Cancer Target Could Mean Earlier Detection, Treatments

February 17, 2015 12:32 pm | by The Wistar Institute | News | Comments

Researchers at The Wistar Institute have made an exciting discovery in a form of ovarian cancer, often considered one of the most difficult-to-treat forms of cancer. In a new study published in the journal Nature Medicine, this potential target could lead to both biomarkers for earlier detection of the disease as well as serve as a basis for new targeted therapies.


Improving Chemo Use in Prostate Cancer

February 17, 2015 12:21 pm | by Thomas Jefferson University | News | Comments

Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease. A study published online in Clinical Cancer Research, researchers have found that a newer member of the taxane family...

Schools Start Treating E-Cigs as Drug Paraphernalia

February 17, 2015 11:58 am | by Michael Felberbaum, AP Tobacco Writer - Associated Press | News | Comments

Some schools are getting tougher on e-cigarettes, even punishing possession of the devices more harshly than regular cigarettes. Read more...

Amid Measles Outbreak, Few Rules on Teacher Vaccinations

February 17, 2015 11:53 am | by Christine Armario, Associated Press | News | Comments

While much of the attention in the ongoing measles outbreak has focused on student vaccination requirements and exemptions, less attention has been paid to another group in the nation's classrooms: Teachers and staff members, who, by and large, are not required to be vaccinated. Read more...


In Rural India, Children Receive Wrong Treatments for Deadly Ailments

February 17, 2015 10:25 am | by Duke Univ. | News | Comments

Few health care providers in rural India know the correct treatments for childhood diarrhea and pneumonia – two leading killers of young children worldwide. But even when they do, they rarely prescribe them properly, according to a new Duke University study. Read more...


Molecular Inhibitor Breaks Cycle that Leads to Alzheimer's

February 17, 2015 10:19 am | News | Comments

A molecule that can block the progress of Alzheimer’s disease at a crucial stage in its development has been identified by researchers in a new study, raising the prospect that more such molecules may now be found. Read more...


Marvel Molecule Could Lead to Inflammatory Disease Treatments

February 17, 2015 10:13 am | by Trinity College Dublin | News | Comments

Scientists from Trinity College Dublin believe that the marvel molecule — MCC950 — could one day be used to treat a myriad of these diseases. Read more...


Lupin, Celon: Development, Licensing for Generic Advair Diskus

February 17, 2015 10:02 am | News | Comments

​Pharma Major Lupin Limited (Lupin) and Celon Pharma S.A. (Celon) announced that they have entered into a definitive agreement under which the companies will jointly develop a fluticasone/salmeterol dry powder inhaler (DPI) product which is a generic version of GlaxoSmithKline's Advair Diskus. Read more...


Liberia Schools Reopen After 6-Month Ebola Closure

February 17, 2015 9:58 am | by Jonathan Paye-Layleh - Associated Press | News | Comments

Students in Liberia began returning to the classroom Monday after a six-month closure during the Ebola epidemic that left thousands dead, lining up in their uniforms to have their temperatures taken before they could enter school gates. Read more...


Aggressive Form of HIV Uncovered in Cuba

February 13, 2015 4:51 pm | by University of Leuven | News | Comments

Engaging in unprotected sex with multiple partners increases the risk of contracting multiple strains of HIV, the virus that causes AIDS. Once inside a host, these strains can recombine into a new variant of the virus. Read more...     


Researchers Test Device to Help Deaf Children Detect Sounds

February 13, 2015 4:48 pm | by Lauran Neergaard, AP Medical Writer | News | Comments

The device goes beyond cochlear implants that have brought hearing to many deaf children but that don't work for tots who lack their hearing nerve. Read more...                 


Ebola Victims Infectious for a Week After Death, Nonhuman Primate Study Finds

February 13, 2015 4:38 pm | by Elizabeth Doughman, Editor-in-Chief, ALN Magazine | News | Comments

The Ebola virus remains viable for at least seven days after death in non-human primates. A new study, published in Emerging Infectious Diseases, suggests that Ebola transmission from deceased individuals may be possible for an extended period of time after death, underscoring the importance of using safe practices for handling corpses. Read more...


Stem Cell Transplants May Work Better than Existing MS Drug

February 13, 2015 4:34 pm | by AAN | News | Comments

Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the online issue of Neurology, the medical journal of the American Academy of Neurology. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.